24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, after the Australian Government accepted advice from the Australian Technical Advisory Group on Immunisation (ATAGI) that it be included in the rollout program.
The recommendations from ATAGI follow Australia’s medicines regulator, the Therapeutic Goods Administration, provisionally approving the Novavax vaccine for us in Australia.